{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:07:04Z","timestamp":1791328024608,"version":"4.3.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T00:00:00Z","timestamp":1445212800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s13277-015-4237-x","type":"journal-article","created":{"date-parts":[[2015,10,19]],"date-time":"2015-10-19T05:19:21Z","timestamp":1445231961000},"page":"3949-3956","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8+ T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression"],"prefix":"10.1007","volume":"37","author":[{"given":"Meimei","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Seeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizhi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongqin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna A.","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,19]]},"reference":[{"key":"4237_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ygyno.2013.03.026","volume":"130","author":"KA Lowe","year":"2013","unstructured":"Lowe KA, Chia VM, Taylor A, O\u2019Malley C, Kelsh M, Mohamed M, et al. An international assessment of ovarian cancer incidence and mortality. Gynecol Oncol. 2013;130:107\u201314.","journal-title":"Gynecol Oncol"},{"key":"4237_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics: 2011. CA Cancer J Clin. 2011;61:69\u201390.","journal-title":"CA Cancer J Clin"},{"key":"4237_CR3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1470-2045(08)70179-7","volume":"9","author":"MP Coleman","year":"2008","unstructured":"Coleman MP, Quaresma M, Berrino F, Lutz JM, De Angelis R, Capocaccia R, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 2008;9:730\u201356.","journal-title":"Lancet Oncol"},{"key":"4237_CR4","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","volume":"25","author":"WE Winter","year":"2007","unstructured":"Winter WE, Maxwell GL, Tian C, Carlson JW, Ozols RF, Rose PG, et al. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:3621\u20137.","journal-title":"J Clin Oncol"},{"key":"4237_CR5","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois Du","year":"2009","unstructured":"Du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzin. Cancer. 2009;115:1234\u201344.","journal-title":"Cancer"},{"key":"4237_CR6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mt.2013.255","volume":"22","author":"AJR McGray","year":"2014","unstructured":"McGray AJR, Hallett R, Bernard D, Swift SL, Zhu Z, Teoderascu F, et al. Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor. Mol Ther. 2014;22:206\u201318.","journal-title":"Mol Ther"},{"key":"4237_CR7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6:295\u2013307.","journal-title":"Nat Rev Immunol"},{"key":"4237_CR8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI31202","volume":"117","author":"TJ Curiel","year":"2007","unstructured":"Curiel TJ. Tregs and rethinking cancer immunotherapy. J Clin Investig. 2007;117:1167\u201374.","journal-title":"J Clin Investig"},{"key":"4237_CR9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","volume":"8","author":"DAA Vignali","year":"2008","unstructured":"Vignali DAA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol. 2008;8:523\u201332.","journal-title":"Nat Rev Immunol"},{"key":"4237_CR10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nm1093","volume":"10","author":"TJ Curiel","year":"2004","unstructured":"Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med. 2004;10:942\u20139.","journal-title":"Nat Med"},{"key":"4237_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clim.2013.07.003","volume":"149","author":"C Govindaraj","year":"2013","unstructured":"Govindaraj C, Scalzo-Inguanti K, Madondo M, Hallo J, Flanagan K, Quinn M, et al. Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin Immunol. 2013;149:97\u2013110.","journal-title":"Clin Immunol"},{"key":"4237_CR12","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ygyno.2009.11.020","volume":"116","author":"JC Barnett","year":"2010","unstructured":"Barnett JC, Bean SM, Whitaker RS, Kondoh E, Baba T, Fujii S, et al. Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Gynecol Oncol. 2010;116:556\u201362.","journal-title":"Gynecol Oncol"},{"key":"4237_CR13","doi-asserted-by":"crossref","unstructured":"Anderson AC. Tim-3, a negative regulator of anti-tumor immunity. Curr Opin Immunol. 2012;213\u201316.","DOI":"10.1016\/j.coi.2011.12.005"},{"key":"4237_CR14","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","volume":"205","author":"RB Jones","year":"2008","unstructured":"Jones RB, Ndhlovu LC, Barbour JD, Sheth PM, Jha AR, Long BR, et al. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med. 2008;205:2763\u201379.","journal-title":"J Exp Med"},{"key":"4237_CR15","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","volume":"189","author":"A Das","year":"2012","unstructured":"Das A, Ellis G, Pallant C, Lopes ARR, Khanna P, Peppa D, et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol. 2012;189:3925\u201335.","journal-title":"J Immunol"},{"key":"4237_CR16","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2010;10:490\u2013500."},{"key":"4237_CR17","doi-asserted-by":"crossref","DOI":"10.4161\/onci.23849","volume":"2","author":"K Sakuishi","year":"2013","unstructured":"Sakuishi K, Ngiow SF, Sullivan JM, Teng MWL, Kuchroo VK, Smyth MJ, et al. TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer. Oncoimmunology. 2013;2, e23849.","journal-title":"Oncoimmunology"},{"key":"4237_CR18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10753-014-0096-7","volume":"38","author":"H Song","year":"2015","unstructured":"Song H, Zhou Y, Li G, Bai J. Regulatory T cells contribute to the recovery of acute lung injury by upregulating Tim-3. Inflammation. 2015;38:1267\u201372.","journal-title":"Inflammation"},{"key":"4237_CR19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.1200162","volume":"189","author":"JP Moorman","year":"2012","unstructured":"Moorman JP, Wang JM, Zhang Y, Ji XJ, Ma CJ, Wu XY, et al. Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection. J Immunol. 2012;189:755\u201366.","journal-title":"J Immunol"},{"key":"4237_CR20","doi-asserted-by":"crossref","unstructured":"Gautron A-S, Dominguez-Villar M, de Marcken M, Hafler DA. Enhanced suppressor function of TIM-3(+) FoxP3(+) regulatory T cells. Eur J Immunol. 2014;1\u20139.","DOI":"10.1002\/eji.201344392"},{"key":"4237_CR21","doi-asserted-by":"crossref","unstructured":"Shevach EM. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity. 2009;636\u201345.","DOI":"10.1016\/j.immuni.2009.04.010"},{"key":"4237_CR22","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","volume":"207","author":"K Sakuishi","year":"2010","unstructured":"Sakuishi K, Apetoh L, Sullivan JM, Blazar BR, Kuchroo VK, Anderson AC. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J Exp Med. 2010;207:2187\u201394.","journal-title":"J Exp Med"},{"key":"4237_CR23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1084\/jem.192.2.295","volume":"192","author":"S Read","year":"2000","unstructured":"Read S, Malmstr\u00f6m V, Powrie F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med. 2000;192:295\u2013302.","journal-title":"J Exp Med"},{"key":"4237_CR24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1074-7613(03)00327-3","volume":"19","author":"P Serra","year":"2003","unstructured":"Serra P, Amrani A, Yamanouchi J, Han B, Thiessen S, Utsugi T, et al. CD40 ligation releases immature dendritic cells from the control of regulatory CD4\u2009+\u2009CD25+ T cells. Immunity. 2003;19:877\u201389.","journal-title":"Immunity"},{"key":"4237_CR25","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1038\/ni1003","volume":"4","author":"F Fallarino","year":"2003","unstructured":"Fallarino F, Grohmann U, Hwang KW, Orabona C, Vacca C, Bianchi R, et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol. 2003;4:1206\u201312.","journal-title":"Nat Immunol"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4237-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4237-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4237-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4237-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T15:43:39Z","timestamp":1559490219000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4237-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,19]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["4237"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4237-x","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,19]]}}}